Narrative review / 2001
Dietary methionine restriction appears safe, feasible, and shows preliminary antitumor activity in advanced cancer.
This review discusses dietary restriction of methionine as a potential strategy for advanced cancer. Preclinical work led to a phase I clinical trial in adults with advanced cancer, where preliminary findings indicated the diet is safe and feasible. The trial also produced preliminary evidence of antitumor activity, including a 25% drop in serum PSA after 12 weeks in a patient with hormone-independent prostate cancer and an objective radiographic response in a patient with renal cell cancer.
- Study type
- Narrative review with phase I trial results
- Who was studied
- Adults with advanced cancer (including specific cases mentioned)
- What was measured
- Safety, feasibility, and preliminary antitumor activity (e.g., PSA levels, radiographic response)
THE PAPER
Can dietary methionine restriction increase the effectiveness of chemotherapy in treatment of advanced cancer?
Epner DE. J Am Coll Nutr, 2001.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.